BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26444755)

  • 1. Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.
    Leh SE; Kälin AM; Schroeder C; Park MT; Chakravarty MM; Freund P; Gietl AF; Riese F; Kollias S; Hock C; Michels L
    J Alzheimers Dis; 2016; 49(1):237-49. PubMed ID: 26444755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.
    Ye BS; Seo SW; Kim CH; Jeon S; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Jang EY; Lee J; Kim JH; Chin J; Lee JM; Kim JH; Seong JK; Kim CH; Choe YS; Lee KH; Na DL
    Neurobiol Aging; 2014 Feb; 35(2):291-300. PubMed ID: 24080178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalamic volume loss as an early sign of amnestic mild cognitive impairment.
    Zidan M; Boban J; Bjelan M; Todorović A; Stankov Vujanić T; Semnic M; Boban N; Kozić D
    J Clin Neurosci; 2019 Oct; 68():168-173. PubMed ID: 31324472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    Fu Z; Zhao M; Wang X; He Y; Tian Y; Yang Y; Han Y; Li S
    J Alzheimers Dis; 2021; 79(3):1121-1132. PubMed ID: 33386805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between visual association memory test and structural changes in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Huang KL; Hsiao IT; Kuo HC; Hsieh CJ; Hsieh YC; Wu YM; Wey SP; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2019 Sep; 118(9):1325-1332. PubMed ID: 30579663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric brain changes in thalamus, corpus callosum and medial temporal structures: mild Alzheimer's disease compared with amnestic mild cognitive impairment.
    Pedro T; Weiler M; Yasuda CL; D'Abreu A; Damasceno BP; Cendes F; Balthazar ML
    Dement Geriatr Cogn Disord; 2012; 34(3-4):149-55. PubMed ID: 22986782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cortical thickness in patients with early-stage versus late-stage amnestic mild cognitive impairment.
    Ye BS; Seo SW; Yang JJ; Kim HJ; Kim YJ; Yoon CW; Cho H; Noh Y; Kim GH; Chin J; Kim JH; Jeon S; Lee JM; Na DL
    Eur J Neurol; 2014; 21(1):86-92. PubMed ID: 24033766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.
    Um YH; Wang SM; Kang DW; Kim NY; Lim HK
    J Alzheimers Dis; 2022; 86(2):565-578. PubMed ID: 35068468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
    Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
    Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology.
    Miotto EC; Brucki SMD; Cerqueira CT; Bazán PR; Silva GAA; Martin MDGM; da Silveira PS; Faria DP; Coutinho AM; Buchpiguel CA; Busatto Filho G; Nitrini R
    J Alzheimers Dis; 2022; 89(1):181-192. PubMed ID: 35871330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape changes of the basal ganglia and thalamus in Alzheimer's disease: a three-year longitudinal study.
    Cho H; Kim JH; Kim C; Ye BS; Kim HJ; Yoon CW; Noh Y; Kim GH; Kim YJ; Kim JH; Kim CH; Kang SJ; Chin J; Kim ST; Lee KH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2014; 40(2):285-95. PubMed ID: 24413620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?
    Chen J; Zhang Z; Li S
    Neurosci Bull; 2015 Feb; 31(1):128-40. PubMed ID: 25595368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters.
    Monacelli F; Borghi R; Cammarata S; Nencioni A; Piccini A; Tabaton M; Odetti P
    J Alzheimers Dis; 2015; 45(1):89-95. PubMed ID: 25471189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Förster S; Buschert VC; Buchholz HG; Teipel SJ; Friese U; Zach C; la Fougere C; Rominger A; Drzezga A; Hampel H; Bartenstein P; Buerger K
    J Alzheimers Dis; 2011; 25(4):695-706. PubMed ID: 21498904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.
    Le Page A; Bourgade K; Lamoureux J; Frost E; Pawelec G; Larbi A; Witkowski JM; Dupuis G; Fülöp T
    J Alzheimers Dis; 2015; 46(1):93-107. PubMed ID: 25720398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease.
    Kjelvik G; Saltvedt I; White LR; Stenumgård P; Sletvold O; Engedal K; Skåtun K; Lyngvær AK; Steffenach HA; Håberg AK
    BMC Neurol; 2014 Aug; 14():168. PubMed ID: 25154749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients.
    Cherubini A; Péran P; Spoletini I; Di Paola M; Di Iulio F; Hagberg GE; Sancesario G; Gianni W; Bossù P; Caltagirone C; Sabatini U; Spalletta G
    J Alzheimers Dis; 2010; 19(4):1273-82. PubMed ID: 20308792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.